Viimane versioon :
03/05/2024
Uurimisrühmad - Faculty of Medical and Health Sciences, University of Auckland   Pdf  
Uus-Meremaa
ülikool
Faculty of Medical and Health Sciences, University of Auckland
Auckland
Viited   Viited   (5)  
1
The Effect of Manufacturer on the Compounding of Omeprazole Suspensions and Their Stability Assessment.
Meissner S, Bansal M, Donamae P, Hanning S, Svirskis D. (d.svirskis@auckland.ac.nz)
Int J Pharm Compound - 2020 - ;24,2:140-147
2
Stability of vincristine sulfate, doxorubicin hydrochloride and etoposide phosphate admixtures in polyisoprene elastromeric pump supporting transition of the EPOCH regimen to oupatient care.
Svirskis D, Behera S, Naidoo N, Beachman J, Raina T, Zhou Y, Berkahn L, Costello I, Gu Y. (y.gu@auckland.ac.nz)
J Oncol Pharm Practice - 2018 - ;25,4:831-840.
3
The Influence of Tablet Formulation, Drug Concentration, and pH Modification on the Stability of Extemporaneously Compounded Levothyroxine Suspensions.
Svirskis D, Lin S.W, Brown H, Sangaroothong A, Wang Z, Xu H, Dean R, Vareed P, Jensen M, Wu Z. (z.wu@auckland.ac.nz)
Int J Pharm Compound - 2018 - ;22,2:164-171
4
An investigation into the stability and sterility of citric acid solutions used for cough reflex testing.
Falconer J.R, Wu Z, Lau H, Sue J, Wang L, Pottinger S, Lee E, Alazawi N, Kalllesen M, Gargiulo D.A, Swift S, Svirskis D. (d.svirskis@auckland.ac.nz)
Dysphagia - 2014 -
5
Chemical Stability of Extemporaneously Compounded Omeprazole Formulations: A methods of compounding.
Garg S, Svirskis D, Al-Kabba M, Farhan S, Komeshi M, Lee J, Liu Q, Naidoo S. ()
Int J Pharm Compound - 2009 - ; 13, 3: 250-253.

Ingredientide nimekiri   Molekulid uuritud   (6)  
Mitmesugune Aerosool Citric acid
Vähiravimite Süsteravim Doxorubicin hydrochloride
Vähiravimite Süsteravim Etoposide phosphate
Hormoonasendusravi Suukaudne lahus Levothyroxine
Prootonpumba inhibiitor Suukaudne lahus Omeprazole sodium
Vähiravimite Süsteravim Vincristine sulfate

  Mentions Légales